Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 32, Issue 2, Pages 183-196
Publisher
Elsevier BV
Online
2020-11-26
DOI
10.1016/j.annonc.2020.11.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
- (2020) Eva Versteijne et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis
- (2020) Mao Ye et al. HPB
- Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
- (2020) Quisette P. Janssen et al. Frontiers in Oncology
- Neoadjuvant Treatment in Pancreatic Cancer
- (2020) Atsushi Oba et al. Frontiers in Oncology
- Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection
- (2020) Wungki Park et al. CLINICAL CANCER RESEARCH
- ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.
- (2020) Paula Ghaneh et al. JOURNAL OF CLINICAL ONCOLOGY
- SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).
- (2020) Davendra Sohal et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019
- (2019) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis
- (2019) Quisette P Janssen et al. JNCI-Journal of the National Cancer Institute
- Ablation treatments in unresectable pancreatic cancer
- (2019) Salvatore Paiella et al. MINERVA CHIRURGICA
- Recent eUpdates to the ESMO Clinical Practice Guidelines on hepatocellular carcinoma, cancer of the pancreas, soft tissue and visceral sarcomas, cancer of the prostate and gastric cancer
- (2019) G Pentheroudakis ANNALS OF ONCOLOGY
- Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study
- (2019) Stefan Heinrich et al. BMC CANCER
- Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
- (2019) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic body radiation therapy for locally advanced pancreatic cancer
- (2019) Jinhong Jung et al. PLoS One
- Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
- (2019) Laura Maggino et al. JAMA Surgery
- Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis
- (2019) Yoon Suk Lee et al. Scientific Reports
- White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease
- (2019) Naveen M. Kulkarni et al. Abdominal Radiology
- Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift
- (2019) Akhil Chawla et al. Frontiers in Oncology
- Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis
- (2019) Long Pan et al. World Journal of Surgical Oncology
- Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer
- (2018) Jin-Young Jang et al. ANNALS OF SURGERY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Use of imaging during symptomatic follow-up after resection of pancreatic ductal adenocarcinoma
- (2018) Vincent P. Groot et al. JOURNAL OF SURGICAL RESEARCH
- International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
- (2018) Shuji Isaji et al. PANCREATOLOGY
- Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
- (2018) Andrew J Aguirre et al. Cancer Discovery
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
- (2018) Pat Gulhati et al. ANNALS OF SURGICAL ONCOLOGY
- Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer
- (2018) Xinchun Liu et al. BMC GASTROENTEROLOGY
- Optimizing the outcomes of pancreatic cancer surgery
- (2018) Oliver Strobel et al. Nature Reviews Clinical Oncology
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis
- (2017) Ali A. Mokdad et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages
- (2016) Kezhong Tang et al. PANCREATOLOGY
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
- (2015) Cristina R. Ferrone et al. ANNALS OF SURGERY
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- AHPBA/SSO/SSAT Sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma
- (2015) Elijah Dixon et al. HPB
- Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer
- (2014) Christina L. Roland et al. ANNALS OF SURGICAL ONCOLOGY
- Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
- (2014) Juan W. Valle et al. JOURNAL OF CLINICAL ONCOLOGY
- Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
- (2014) Maximilian Bockhorn et al. SURGERY
- Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer
- (2013) Ryan P. Merkow et al. ANNALS OF SURGERY
- Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
- (2013) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis
- (2013) C. P. Xu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer
- (2011) Jerome Martin Laurence et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant Therapy
- (2011) Skye C. Mayo et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search